ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Health Care / TDOC / options
PNTG (64) USPH (70) INNV (52) WGS (47) ⌘ Pro Terminal →

Teladoc Health Inc. (TDOC) Options Positioning, Max Pain & Unusual Sweeps

$8.63 +1.41% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $8.64

Teladoc Health Inc. (TDOC) carries a Roarable Rating of D+ (Sell) with 55/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ • SELL / AVOID Cap $1.55B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on TDOC Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is TDOC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Teladoc Health Inc. (NYSE: TDOC) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 55/100 at a spot price of $8.63 (+1.41% 1D, market cap $1.55B). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 11/20, and Executive Insider Alignment 13/20. Across 1015 tracked Health Care issuers, TDOC ranks #205 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does TDOC compare to PNTG and USPH in the Health Care sector?
▼

Within the Health Care sector (Medical/Nursing Services), TDOC carries a Roarable D+ (55/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -17.0%. By comparison, PNTG (The Pennant Group Inc.) holds a C grade (64/100 RQD, P/E 50.2x, ROIC 11.0%, cap $1.46B) and USPH (U.S. Physical Therapy Inc.) posts a B- grade (70/100 RQD, P/E 32.6x, ROIC 11.5%, cap $1.28B). Among the 5-stock peer group, USPH leads on earnings multiple (32.6x) while USPH leads on capital efficiency (11.5% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for TDOC?
▼

Per TDOC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001477449), Teladoc Health Inc. generated $2.53B in revenue (-1.5% YoY), -$200.3M in net income, and $285.5M in free cash flow against $2.86B in total assets and $662.7M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $8.64 (+0.06%)🧬 Cannibal Buyback (-1.52% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 11.3% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 55/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.5% avg 90D alpha vs SPY • 51.4% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D+
025507510055
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D+
Cash (6)Whales (15)SEC (10)Macro (11)CEO (13)
Each axis scored 0–20
12M PRICE TARGET CONE-1.4% Base Target
$10 Bull$9 Base$7 Bear
📬 FREE TDOC RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for TDOC)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (55/100 Composite)
🔍 WHY TDOC SCORES 55/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+15/20 pts (27% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▲ #2 Bullish Driver: Insider Conviction & Share Dilution+13/20 pts (24% of score)

SEC Form 4 / 13F Thermometer: 65% Net Buy • Cannibal Buyback (-1.52% YoY Shares)

▼ #1 Drag / Risk Factor: Cash Engine Quality6/20 pts (-14 pt drag)

Capital intensity & 0% operating margin leave 14 pts on the table

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
47
Grade D$5.81+8.4% Next Q
Q2 (-2Q)
50
Grade C-$6.30+9.2% Next Q
Q3 (-1Q)
52
Grade C-$6.88+25.4% Next Q
Current
55
Grade D+$8.63-0.5% Hist 90D α
Trajectory: D (47) → D+ (55)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the TDOC Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 55/100 (D+) score, TDOC faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-1.52% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($6.38) or 200D SMA ($6.51) invalidates the momentum regime and cuts Target Base ($8.51) toward Bear Floor ($6.64).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $TDOC• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “TDOC Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 55%NO 45%Trade / Inspect Odds →
CALL VS. PUT WHALE SHARE
— (No Active Options Snapshot)
Put/Call Ratio: — (No Active Options Snapshot)
MAX-PAIN EXPIRATION MAGNET
— (No Active Options Snapshot)
No active options chain max-pain snapshot on file
HISTORICAL 20D VOLATILITY SWING
±12.5%
Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (TDOC)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for TDOC.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring TDOC)

  • ✓Walkthrough of TDOC's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
TDOC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +30.17%⚡ TESTING RESISTANCE
2026-11-03O $8.73H $8.73L $8.51C $8.63VOL 8.16M
RES: $8.95SUP: $5.05SMA50: $6.38SMA200: $6.51
$10.20$8.91$7.61$6.31$5.02RES $8.95SUP $5.05$8.632026-05-042026-06-182026-08-052026-09-212026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

TDOC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 TDOC Butterfly Map → + Track TDOC →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
24.7%/yr Implied 5Y Growth

vs. -1.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on TDOC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for TDOC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for TDOC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (TDOC)

Health Care Rank #205 of 1015 ⚔️ PNTG vs TDOC Full Matrix →

1. Head-to-Head Health Care Peer Comparison (TDOC vs. PNTG, USPH, INNV, WGS)

Industry: Medical/Nursing Services (29 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Teladoc Health Inc. (TDOC) ranks #205 by composite RQD confidence (55/100, grade D+) and #297 by equity capitalization ($1.55B). Within this direct 5-issuer industry benchmark cohort, USPH leads on earnings valuation at 32.6x trailing P/E, while USPH leads on capital efficiency and profitability with 11.5% ROIC and 19.2% gross margin. USPH currently holds the highest overall quantitative score in the immediate peer group at 70/100 (B-) compared with TDOC at 55/100 (D+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
TDOC ACTIVE
Teladoc Health Inc.
D+ 55/100 — — -17.0% +1.41% $1.55B Benchmark Subject
PNTG
The Pennant Group Inc.
C 64/100 50.2x — 11.0% -2.78% $1.46B /pntg-vs-tdoc →
USPH
U.S. Physical Therapy Inc.
B- 70/100 32.6x 19.2% 11.5% -1.08% $1.28B /usph-vs-tdoc →
INNV
InnovAge Holding Corp.
D+ 52/100 — 18.0% -10.2% -2.94% $1.25B /innv-vs-tdoc →
WGS
GeneDx Holdings Corp. (Class A)
D 47/100 — 69.7% -4.1% -7.20% $2.06B /wgs-vs-tdoc →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001477449 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Teladoc Health Inc. (TDOC) reported GAAP revenue of $2.53B (-1.5% vs. FY2024 revenue of $2.57B , and -2.8% cumulative change since FY2023) , GAAP net income of -$200.3M, operating cash flow of $294.4M, and free cash flow of $285.5M (+0.9% YoY). On the balance sheet, TDOC closed FY2025 with $2.86B in total assets against $662.7M in total debt (Altman Z-Score: 0.45, Piotroski F-Score: 7/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $2.53B -$200.3M $294.4M $285.5M $2.86B $662.7M
FY2024 (FY) 2024-12-31 $2.57B -$1.00B $293.7M $282.9M $3.52B $911.5M
FY2023 (FY) 2023-12-31 $2.60B -$220.4M $350.0M $232.9M $3.12B $730.8M

3. TDOC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is TDOC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Teladoc Health Inc. (NYSE: TDOC) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 55/100 at a spot price of $8.63 (+1.41% 1D, market cap $1.55B). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 11/20, and Executive Insider Alignment 13/20. Across 1015 tracked Health Care issuers, TDOC ranks #205 in composite RQD confidence.

How does TDOC compare to PNTG and USPH in the Health Care sector?

Within the Health Care sector (Medical/Nursing Services), TDOC carries a Roarable D+ (55/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -17.0%. By comparison, PNTG (The Pennant Group Inc.) holds a C grade (64/100 RQD, P/E 50.2x, ROIC 11.0%, cap $1.46B) and USPH (U.S. Physical Therapy Inc.) posts a B- grade (70/100 RQD, P/E 32.6x, ROIC 11.5%, cap $1.28B). Among the 5-stock peer group, USPH leads on earnings multiple (32.6x) while USPH leads on capital efficiency (11.5% ROIC).

What are the biggest fundamental strengths and SEC risk factors for TDOC?

Per TDOC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001477449), Teladoc Health Inc. generated $2.53B in revenue (-1.5% YoY), -$200.3M in net income, and $285.5M in free cash flow against $2.86B in total assets and $662.7M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins. Institutional options positioning shows a 50% call / 50% put premium split.

Where is TDOC trading relative to its 50-day, 200-day, and 52-week technical levels?

TDOC last traded at $8.63 (+1.41% on volume of 6,065,928 shares), positioning the stock +35.27% above its 50-day simple moving average ($6.38) and +32.57% above its 200-day simple moving average ($6.51). Across its 52-week range of $4.40 to $9.89, TDOC sits at the 77.0% percentile with a 14-day RSI of 74.1 (OVERBOUGHT (>70)) and an implied next-earnings move of ±12.5% ($7.55 to $9.71).

Direct Sub-Reports: TDOC RQD Cockpit TDOC 12M Forecast TDOC Earnings & Move TDOC Dividends & DRIP TDOC Insiders & 13F TDOC Whale Options TDOC Profit Sankey TDOC News & Why
ROARABLE RATING BRIEF • RQD 55/100 (D+) ✓ SEC XBRL & RQD VERIFIED

TDOC — Teladoc Health Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Teladoc Health Inc. (TDOC) earns a live Roarable RQD composite score of 55/100, corresponding to a D+ letter grade (Roarable Sell) at a spot price of $8.63 (+1.41% 1D, market capitalization $1.55B).

  • Fundamental Cash Engine (6/20): Anchored by return on invested capital (ROIC) of -17.0%, gross margin of —, operating margin of -10.4%, and free cash flow yield of 18.00%.
  • Whale 13F & Options Flow (15/20) + Insider Conviction (13/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (11/20) + Forensic Balance Sheet (10/20): Incorporates a 1.08x equity beta, Altman Z-Score of 0.45, Piotroski F-Score of 7/9, and Debt/Equity of 0.45x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Teladoc Health Inc. Is classified under the Health Care sector and the Medical/Nursing Services industry, trading on the NYSE. The issuer operates in this industry with a market capitalization of $1.6B. — describes the products and services sold, the customer base, or the revenue model.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Teladoc Health Inc. (TDOC) reported $2.53B in annual revenue (up from $2.57B in FY2024, -1.5% YoY) and -$200.3M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($2.60B revenue, -$220.4M net income) through FY2025, TDOC scaled operating cash flow to $294.4M and free cash flow to $285.5M, backed by $2.86B in total assets against $662.7M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D+ • RQD 55/100): Big institutional funds and options desks are actively positioning on the bullish side. Free cash flow yield of 18.00% and institutional whale pillar of 15/20. With Fundamental Cash Engine at 6/20 and Institutional Whale Flow at 15/20, sustained execution supports upside toward the upper end of the $4.40 – $9.89 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins. Investors must weigh current valuation against -10.4% operating margins and a 1.08x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Sector classification is Health Care and industry is Medical/Nursing Services. — for upstream or downstream dependencies, sector correlation beyond beta, or second-order bottlenecks.

  • Key Question #1: Can TDOC sustain or expand its -10.4% operating margin and -17.0% ROIC against Medical/Nursing Services peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $2.53B and free cash flow of $285.5M, how will capital allocation balance growth reinvestment against $662.7M in total debt?
  • Key Question #3: How sensitive is TDOC's 32.0x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.08x)?

TDOC Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Teladoc Health Inc. (TDOC) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to TDOC Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

TDOC Bull vs. Bear Conversation Board — What's Your Call at $8.63?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON TDOC 🐻 33% BEARISH CONVICTION
1. Pick Your Side on TDOC:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
BR BreakoutHunter RQD DEBATE OPENER • Swing & Catalyst Trader 🐂 BULLISH 🎯 Target: $10.89 (+28.0%)
📌 Pinned Debate

Reported FCF yield of 18% indicates substantial cash generation relative to the $1.59B market capitalization.

Picked up a starter position in TDOC in my $100K Virtual Cash book at $8.51. Reported FCF yield of 18% indicates substantial cash generation relative to the $1.59B market capitalization.. Trading inside a $4.40–$9.89 52-week range with 18.0% FCF yield gives solid downside support if Medical/Nursing Services multiples expand this quarter.

SectorRotator 🐂 BULL

@BreakoutHunter Agree on the RQD 55/100 quality, though with 1.08 beta I'm scaling in with half-size at $8.51 and keeping dry powder in case we test $7.91.

FA FadeTheHype RQD DEBATE OPENER • Contrarian Tape Reader 🐻 BEARISH 🎯 Target: $6.72 (-21.0%)
Spot @ $8.51

ROIC of -17%, operating margin of -10.4%, and EPS (TTM) of -1.1 show the business is not yet earning returns on its capital.

Fading this rally in TDOC at $8.51. ROIC of -17%, operating margin of -10.4%, and EPS (TTM) of -1.1 show the business is not yet earning returns on its capital.. With a beta of 1.08 and the stock sitting at $8.51 (52-wk range $4.40–$9.89), the easy multiple expansion is already priced in.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%